[{"Assets_0_Q1_USD":115704000.0,"CommonStockSharesOutstanding_0_Q1_shares":14443569.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-3215000.0,"NetIncomeLoss_1_Q1_USD":-4111000.0,"StockholdersEquity_0_Q1_USD":109486000.0,"Ticker":"KRYS","CIK":"1711279","name":"KRYSTAL BIOTECH, INC.","OfficialName":"Krystal Biotech Inc. Common Stock","form":"10-Q","period":"20190331","fy":"2019.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1834745088.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20190507"}]